Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
607 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Recruiting Registry of Philadelphia-Negative Myeloproliferative Neoplasms
Condition: Hematologic Diseases
Intervention:
22 Not yet recruiting Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
Conditions: HTLV-I Infections;   Tropical Spastic Paraparesis
Intervention: Drug: "Raltegravir" and "Zidovudine"
23 Recruiting Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Condition: Tumor With Bone Metastasis
Interventions: Other: quality of life questionaries;   Drug: intravenous or oral bone antiresorptive treatments
24 Recruiting Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Conditions: Prostate Cancer;   Bone Metastases
Intervention: Drug: [68Ga]P15-041
25 Recruiting A Study to Collect Data About Analgesia in Patients With Bone Metastasis
Condition: Bone Metastasis
Interventions: Other: Questionnaires completion;   Other: Clinical Pain Assessments
26 Recruiting The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
Condition: Bone Metastasis
Interventions: Procedure: Stabilisation of (impending) pathological fracture;   Radiation: Radiotherapy of bone metastasis
27 Recruiting Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
Condition: Bone Metastasis
Interventions: Drug: fentanyl transmucosal;   Drug: Placebo
28 Recruiting Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS
Condition: Bone Metastases
Intervention: Radiation: Radiotherapy
29 Recruiting Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Condition: Bone Metastases
Intervention: Other: blood sampling, the SF-36 questionnaire
30 Recruiting Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases
Condition: Bone Metastases
Interventions: Radiation: Conventional Radiotherapy;   Radiation: Biological image-guided radiotherapy with conventional dose.;   Radiation: Biological image-guided SBRT with dose-escalation.
31 Recruiting A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms
Condition: Myeloproliferative Neoplasms
Intervention: Drug: SGI-110
32 Not yet recruiting Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders
Condition: Myeloproliferative Neoplasms
Intervention:
33 Recruiting Italian Network MDS Registry
Condition: Myelodysplastic-Myeloproliferative Diseases
Intervention:
34 Recruiting PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
Conditions: Primary Myelofibrosis;   Myeloproliferative Disorders
Interventions: Procedure: Allogeneic hematopoietic stem cell transplantation;   Drug: Busulfan;   Drug: Fludarabine monophosphate;   Drug: Cyclophosphamide;   Drug: Ruxolitinib
35 Not yet recruiting Exploring the Mechanisms of Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine Kinase Inhibitors in 3d Model Niche Endosteal
Condition: Myeloproliferative Disorders
Intervention:
36 Recruiting Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)
Conditions: Leukemia;   Lymphoma;   Myeloma;   Myeloproliferative Diseases
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Drug: Rabbit ATG;   Radiation: Total Body Irradiation (TBI);   Procedure: Cord Blood Infusions;   Drug: Rituximab;   Drug: Cyclophosphamide;   Procedure: Natural Killer Cell Infusion;   Drug: Melphalan;   Drug: Mesna
37 Recruiting Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Condition: Myeloproliferative Diseases
Interventions: Drug: Ruxolitinib;   Drug: Pracinostat;   Behavioral: Questionnaire
38 Recruiting Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Condition: Myeloproliferative Neoplasms
Interventions: Drug: Ruxolitinib;   Drug: Decitabine
39 Recruiting Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)
Condition: MDS
Interventions: Procedure: Allogeneic Hematopoietic Cell Transplant;   Procedure: Hypomethylating Therapy / Best Supportive Care;   Drug: Reduced Intensity Conditioning
40 Recruiting Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms
Condition: Chronic Myeloproliferative Neoplasms
Intervention: Drug: Givinostat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.